-
1 week ago | 
medcitynews.com | Frank Vinluan |Tomasz Rezik
The journey of rare disease patients and their families can be a long one marked by misdiagnoses, and so it is for those who have the ultra-rare disorder with the abbreviated name PMM2-CDG. This enzyme deficiency leads to muscle problems and developmental delays that are often mistaken for other diseases, said Steven Axon, CEO of startup Glycomine. PMM2-CDG is genetic, but it’s not currently part of newborn screening.
-
1 week ago | 
medcitynews.com | Tim Church |Tomasz Rezik
Dr. Tim Church MD, MPH, PhD, and Chief Medical Officer of Wondr Health is one of the country’s leading clinical thought leaders in exercise and obesity research. As the author of over 300 published clinical articles, Dr. Church has received many awards for his research in preventive health. At Wondr Health, Dr. Church leads the development of program curriculum, which is inspired by his medical expertise.
-
1 week ago | 
medcitynews.com | Marissa Plescia |Tomasz Rezik
It’s no secret that small to mid-sized businesses are struggling to handle healthcare costs, and a report released last week from JPMorganChase Institute is adding to that evidence. The report found that roughly one-third of small businesses discontinued their health insurance coverage from one year to the next. For instance, 32% of nonemployer firms—businesses without paid employees—that paid health insurance premiums in 2018 no longer did so in 2019.
-
1 week ago | 
medcitynews.com | Frank Vinluan |Tomasz Rezik
Pfizer is playing catch-up in the crowded field of obesity medicines, but it hoped to compete with a daily pill alternative to currently available injectable GLP-1 products. Instead, Pfizer is stopping development of its drug, danuglipron, after a liver complication emerged in a clinical trial. The pharmaceutical giant was evaluating danuglipron in two Phase 1 dose-optimization studies. The company said Monday a patient in one of those studies experienced a potential drug-induced liver injury.
-
2 weeks ago | 
medcitynews.com | Frank Vinluan |Tomasz Rezik
An experimental Alzheimer’s disease therapy designed by Alzheon to reduce depositions of amyloid plaque in the brain failed to beat a placebo in a Phase 3 study, the latest blow to a drug whose history is marked by clinical trial shortfalls. The twice-daily pill, valiltramiprosate, did not meet the main clinical trial goal of slowing cognitive decline measured at 78 weeks, Alzheon announced Thursday.
-
3 weeks ago | 
medcitynews.com | Frank Vinluan |Tomasz Rezik
Thousands of FDA workers lost their jobs this week. The most prominent was Peter Marks, director of the agency’s Center for Biologics Evaluation and Research (CBER). While this position has been described as the FDA’s top vaccine official, it became much more under Marks. Marks was appointed leader of CBER in 2016 and his tenure came alongside the emergence of new therapeutic modalities, such as cell and gene therapies.
-
Jan 10, 2025 | 
thehrdirector.com | Tomasz Rezik
Leadership is the lifeblood of any business. A leader’s style can drive a team to greatness or act as a deterrent to creativity and productivity. Everything from how a leader communicates and delegates tasks to their decision-making directly influences a company’s efficiency and performance. But how can leaders better understand their style of leadership to improve and support their teams most effectively? Through leadership style assessments.
-
Dec 10, 2024 | 
kalkinemedia.com | Tomasz Rezik
The business landscape is shifting rapidly, with technology redefining how companies operate, engage with customers, and scale. Among the most transformative changes is the evolution of payment systems. What used to be a straightforward transaction involving cash or cards has expanded to include digital wallets, buy-now-pay-later (BNPL) services, and automated invoicing. For businesses, embracing these trends has become a strategic necessity, not a choice.
-
Dec 6, 2024 | 
theapopkavoice.com | Tomasz Rezik
Looking to surprise someone with a nice gift? No matter what you choose, think of giving an unforgettable experience instead of an everyday item. Luxury gourmet cooking classes or a romantic dinner cruise in NYC are bonding experiences that can create a lot of memories. Those one-day experiences feel like more than just a day out. You’re doing something different — something you wouldn’t necessarily do otherwise.
-
Dec 4, 2024 | 
bitrebels.com | Tomasz Rezik
There’s nothing like a dining room that feels chic yet inviting. And, whether you’re entertaining a crowd or just sitting down with your nearest and dearest, kitchen chairs influence the mood of the room. They’re more than places to park your, well, seat. They’re the building blocks of both form and function and of your entire eating area. Buying the right chairs is, therefore, about more than just stocking your home with seating.
